ALS Research
With your support, our research funding fuels global collaboration to expedite the discovery of treatments and a cure for ALS.
Every aspect of our work is dedicated to advancing our mission of discovering effective treatments and ultimately eradicating ALS. This underscores the critical importance of funding exceptional ALS research.
We prioritize funding the most promising research endeavors and actively cultivate innovative partnerships spanning government, industry, academia, and other nonprofit organizations. Additionally, we invest in emerging talent, nurturing young scientists to drive innovation.
National Guidelines for ALS Genetic Testing
Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed and published guidelines for genetic testing and counseling for people living with ALS.
National ALS Registry
The National ALS Registry may be the single largest ALS research project ever created and is designed to identify ALS cases from throughout the entire United States.
Northeast ALS Consortium (NEALS)
NEALS' mission is to rapidly translate scientific advances into clinical research and new treatments for people with Amyotrophic Lateral Sclerosis (ALS) and motor neuron disease.
Robert Packard Center for ALS Research
The Robert Packard Center for ALS Research at Johns Hopkins and ALS United are pleased to announce a collaboration to jointly fund preclinical basic science research into amyotrophic lateral sclerosis (ALS). This partnership reflects both organizations’ commitment to accelerating breakthrough discoveries that will advance understanding of ALS and bring hope to those affected by the disease.
National Institue of Neurological Disorders and Stroke
NINDS offers information on news, upcoming events, current ALS specific funding opportunities, featured initiatives and programs, and ALS research resources.
You Are Part of the Solution
Your gift will help support research to find treatments and a cure for ALS.
Investing in Promising ALS Research Pathways
At ALS United Rocky Mountain, we strategically direct ALS research funding toward the most promising scientific pathways to accelerate treatments. Our approach prioritizes innovative projects with high potential for near-term impact on amyotrophic lateral sclerosis patients. By fostering collaborations between leading academic institutions, pharmaceutical partners, and government agencies, we create synergistic research ecosystems that overcome traditional barriers in neurological disorders research.
We maintain a dedicated focus on translating laboratory discoveries into clinical applications, particularly supporting clinical trials for ALS that show promise for disease modification. Our 2025 research portfolio includes targeted investments in genetic therapies, neuroprotective agents, and personalized medicine approaches. This multi-pronged strategy addresses the complex nature of motor neuron disease from multiple angles, increasing our chances of meaningful breakthroughs.
Through our competitive grant programs, we identify and fund exceptional scientists pursuing novel ALS cure research concepts. We specifically allocate resources to support early-career researchers bringing fresh perspectives to the field. This investment in emerging talent cultivates the next generation of ALS specialists while accelerating discovery timelines. Our rigorous peer-review process ensures every dollar contributes to high-impact science with tangible patient benefits.
Our partnership model extends beyond financial support to include data sharing, resource coordination, and advocacy for regulatory advancement. By serving as a catalyst between research entities, we help overcome fragmentation in the ALS research landscape. This collaborative infrastructure enables faster validation of therapeutic targets and more efficient clinical trial design, bringing us closer to effective treatments.